| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | Japan | 5 | |
| #3 | Republic of Korea | 5 | |
| #4 | Mexico | 5 | |
| #5 | Canada | 4 | |
| #6 | China | 4 | |
| #7 | Singapore | 4 | |
| #8 | Brazil | 3 | |
| #9 | United Kingdom | 3 | |
| #10 | Israel | 3 | |
| #11 | United States | 3 | |
| #12 | WIPO (World Intellectual Property Organization) | 2 | |
| #13 | Australia | 1 | |
| #14 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Specific use of cosmetics |
| # | Name | Total Patents |
|---|---|---|
| #1 | Dobak John Daniel | 43 |
| #2 | Locke Kenneth Walter | 28 |
| #3 | Kemmerer Chris | 12 |
| #4 | Kenneth Walter Locke | 2 |
| #5 | Daniel Dobak John | 1 |
| #6 | John Daniel Dobak | 1 |
| #7 | Walter Locke Kenneth | 1 |
| #8 | Dobak John D | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN105832681A | Selective, lipophilic, and long-acting beta agonist mono-therapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging | |
| EP2077830A1 | Methods, compositions, and formulations for the treatment of thyroid eye disease | |
| US2007014843A1 | Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |